Skip to main content
FinSpry Logo
FinSpry
NTLA logo
NTLA
(NASDAQ)
Intellia Therapeutics, Inc.
$13.13-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Intellia Therapeutics (NTLA) Stock Price & Financial Analysis

Intellia Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$12.47 - $13.27
52-Week High$28.25
52-Week Low$5.90
Open$12.69
Volume2.75M
Average Volume (3M)2.75M
Market Cap1.42B
Shares Outstanding108.38M
Price to Sales (P/S)21.25
Price to Book (P/B)2.14
EV/EBITDA-3.22
Revenue (TTM)67.67M
Net Income (TTM)-412.69M
Free Cash Flow (TTM)-395.87M
EPS (TTM)$-3.81
Profit Margin-609.85%
Operating Margin-651.67%
Return on Equity (ROE)-61.47%
Debt to Equity0.14
50-Day MA$13.17
200-Day MA$12.77
52-Week Change99.40%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Intellia Therapeutics

What is the current stock price for NTLA?

As of the latest trading session, NTLA stock trades at $13.13. The 52-week range is $5.90–$28.25, with a day range of $12.47–$13.27.

What is the P/E ratio for NTLA?

The P/E ratio (Price-to-Earnings) for NTLA is shown in the Key Statistics section. This valuation metric helps compare Intellia Therapeutics, Inc. to industry peers.

Does NTLA pay dividends?

Intellia Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NTLA?

Based on 8 analysts, the consensus for NTLA is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NTLA?

Intellia Therapeutics's market capitalization is $1.42B, classifying it as a small-cap company. Intellia Therapeutics operates in the Healthcare sector within the Biotechnology industry.